If a doctor or dentist has prescribed cyclobenzaprine (or a similar muscle relaxant) for your TMJ pain, it's reasonable to want to know whether it's actually backed by evidence, or just a generic reach for anything that might help.
What the evidence shows
Cyclobenzaprine specifically has research support for myofascial (muscle-related) TMD pain. In clinical studies, a nightly 10mg dose outperformed both placebo and a comparison medication for reducing jaw pain upon waking. This puts it on firmer evidentiary ground than a lot of TMD treatments.
The important caveat
Despite that research support, a 2023 BMJ clinical practice guideline specifically recommends against using cyclobenzaprine for chronic TMJ pain. The distinction is short-term versus long-term use: muscle relaxants are generally intended for acute flares over two weeks or less, not as an ongoing daily medication. Side effects — drowsiness, dry mouth, impaired coordination — and dependence risk make it a poor fit for long-term management.
Where it actually fits
- Good fit: a short course during a significant muscle-driven flare, alongside other conservative measures
- Poor fit: daily long-term use as a primary TMD management strategy
- Not well-suited for: TMD that's primarily joint-related (arthritis, disc displacement) rather than muscle-related — muscle relaxants target muscle tension specifically
If you're in an acute flare right now, see our TMJ Flare-Up Relief guide for the non-medication side of acute care. For the longer-term, addressing the muscle tension directly through our Bruxism & Overuse Relief program is a more sustainable approach than relying on medication indefinitely.
For muscle pain that's localized to specific knots rather than more generalized, trigger point injections are a more targeted medical option.